For UK HealthTech companies
You're getting meetings with procurement but not the clinicians who actually use your product
In NHS technology adoption, clinical champion is not a nice-to-have, it's a prerequisite. Procurement decisions that lack clinical advocacy rarely conclude positively. Getting to the right clinician early changes everything.
Cost of Inaction
Enter your target accounts, live deployments today, average contract value, and achievable conversion rate. The calculator shows the annual revenue gap above today's contracts.
How it breaks down
- Current contracted revenue£270,000
- Revenue at target penetration£324,000
Two minutes, no typing, and I read every one myself.
From Paul
Tell me where that £54,000 is coming from, and I'll come back with the three things to fix first.
A few quick questions, about two minutes, and no typing. I read every one myself and reply with the three things costing you most and where I'd start. If it's useful, we talk. If not, you've still got a clear picture.
No obligation, no sales call unless you ask for one, and nothing automated lands in your inbox.
Paul, Solvable
- Engagement defaults to procurement rather than clinical users
- No plan to reach the clinicians who drive adoption
- Lack of clinical relationships and references
- The value case is not framed for a clinical audience
How to fix it
Identify the clinical users and decision-makers, not just procurement Build a clinical engagement plan with the evidence they care about Use existing champions to reach the people who drive adoption
Frequently asked questions
Why does this problem persist?
Procurement is the easiest door to reach but cannot champion the product There is no plan to engage the clinicians who actually use it Field teams lack the clinical relationships to open those doors
This is exactly what I do with UK private practices. Answer the few questions above and I'll come back personally with where to start. Paul.